Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Alafenamide

Common brands: Genvoya, Truvada, Viread, Stribild, Biktarvy

Top reporter: Gilead Sciences, Inc.

Cytochrome P450 3A Inhibitor [EPC]Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Protease Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
9,947
Total Reports
4,838
Serious Reports
197
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.98%)

Patient Demographics

Male
7,219
Female
2,407

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Elvitegravir, Cobicistat, Emtricitabine, / Tenofovir Alafenamide.

# Reaction Reports % of Total
1 BONE DENSITY DECREASED 4,509
12.1%
2 CHRONIC KIDNEY DISEASE 2,614
7.0%
3 BONE LOSS 2,417
6.5%
4 OSTEONECROSIS 2,385
6.4%
5 TOOTH LOSS 2,256
6.0%
6 MULTIPLE FRACTURES 2,136
5.7%
7 RENAL FAILURE 2,094
5.6%
8 OSTEOPOROSIS 1,937
5.2%
9 RENAL INJURY 1,919
5.1%
10 PAIN 1,864
5.0%
11 EMOTIONAL DISTRESS 1,809
4.8%
12 SKELETAL INJURY 1,649
4.4%
13 ANXIETY 1,641
4.4%
14 ANHEDONIA 1,567
4.2%
15 OSTEOPENIA 1,202
3.2%
16 ECONOMIC PROBLEM 684
1.8%
17 BLOOD CREATININE INCREASED 570
1.5%
18 RENAL IMPAIRMENT 559
1.5%
19 ACUTE KIDNEY INJURY 526
1.4%
20 TOOTH INJURY 408
1.1%
21 DEPRESSION 329
0.9%
22 FRACTURE 321
0.9%
23 BONE DENSITY ABNORMAL 298
0.8%
24 NEPHROPATHY 278
0.7%
25 DRUG INTERACTION 266
0.7%
26 VITAMIN D DEFICIENCY 247
0.7%
27 FOOT FRACTURE 228
0.6%
28 FATIGUE 225
0.6%
29 BONE DEMINERALISATION 199
0.5%
30 WEIGHT INCREASED 187
0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.